Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

FDA Safety Reports: Firms Want Advance Notice Before Public Release

This article was originally published in The Pink Sheet Daily

Executive Summary

PDUFA renewal could establish process that allows firms early warnings about Sentinel and other safety data announcements.

Advertisement

Related Content

PDUFA VI: Breakthrough Issues Among FDA Priorities
PDUFA Negotiations Begin With FDA Seeking Review System Reform
FDA’s “Early Communication” On Pancreatitis Risk For Incretin Mimetics Draws Clinician Ire

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS079049

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Add a personalized Question to your Analyst

Cancel